相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
Lisa Greene et al.
MOLECULAR CANCER RESEARCH (2019)
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
Alexander J. Muller et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome
Alice Russell et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases
Fanni A. Boros et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2018)
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
Todd A. Triplett et al.
NATURE BIOTECHNOLOGY (2018)
Kynurenine pathway in depression: A systematic review and meta-analysis
Kamiyu Ogyu et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies
Danilo Arnone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Understanding the Pathophysiology of Psychological Distress and Pancreatic Cancer: A Systematic Review
Travis M. Bettison et al.
PANCREAS (2018)
A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer
Joyce Y. Huang et al.
PLOS ONE (2018)
A promising new cancer drug has hit a major setback, raising questions about whether the field is moving too fast
Ken Garber
SCIENCE (2018)
Discovery of indoleamine 2,3-dioxygenase inhibitors using machine learning based virtual screening
Hongao Zhang et al.
MEDCHEMCOMM (2018)
Neuroimmunology of Behavioral Comorbidities Associated with Cancer and Cancer Treatments
Jessica C. Santos et al.
FRONTIERS IN IMMUNOLOGY (2018)
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas A Phase 2 Clinical Trial
Maud Toulmonde et al.
JAMA ONCOLOGY (2018)
Pancreatic Cancer-Associated Depression: A Case Report and Review of the Literature
Adam F. Barnes et al.
PANCREAS (2018)
Pilot Study of Metabolomics and Psychoneurological Symptoms in Women With Early Stage Breast Cancer
Debra E. Lyon et al.
BIOLOGICAL RESEARCH FOR NURSING (2018)
Cancer and inflammation
Lance L. Munn
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2017)
The risk of being depressed is significantly higher in cancer patients than in the general population: Prevalence and severity of depressive symptoms across major cancer types
T. J. Hartung et al.
EUROPEAN JOURNAL OF CANCER (2017)
Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model
Xiangjing Meng et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2017)
Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery
Jasmine Eshragh et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2017)
Sleep disturbance and kynurenine metabolism in depression
Hyong Jin Cho et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders
Katherine O'Farrell et al.
NEUROPHARMACOLOGY (2017)
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
Giuseppe Lucarelli et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer
Dongfang Tang et al.
ONCOTARGET (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach
Andreas Baranyi et al.
PEERJ (2017)
Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder
Hidehiro Umehara et al.
SCIENTIFIC REPORTS (2017)
Depression in cancer: The many biobehavioral pathways driving tumor progression
Beatrice Bortolato et al.
CANCER TREATMENT REVIEWS (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
Knut A. Hestad et al.
FRONTIERS IN PSYCHOLOGY (2017)
Depression and mortality in a longitudinal study: 1952-2011
Stephen E. Gilman et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)
Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants
Alessandra Borsini et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
Tao Zhang et al.
CHINESE MEDICAL JOURNAL (2017)
Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?
David Baumeister et al.
PSYCHOPHARMACOLOGY (2016)
Low-grade inflammation predicts persistence of depressive symptoms
A. Zalli et al.
PSYCHOPHARMACOLOGY (2016)
Understanding the role of the kynurenine pathway in human breast cancer immunobiology
Benjamin Heng et al.
ONCOTARGET (2016)
9 Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality
Hui Zuo et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder
Timothy B. Meier et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Aberrant Kynurenine Signaling Modulates DNA Replication Stress Factors and Promotes Genomic Instability in Gliomas
April C. L. Bostian et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
Eunsoo Won et al.
CURRENT NEUROPHARMACOLOGY (2016)
Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction
Hannah R. Wardill et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism
Lauren M. F. Merlo et al.
JOURNAL OF IMMUNOLOGY (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression
Nilay Hepgul et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus
Jennifer C. Felger et al.
PHYSIOLOGY & BEHAVIOR (2016)
Role of neuro-immunological factors in the pathophysiology of mood disorders
Anindya Bhattacharya et al.
PSYCHOPHARMACOLOGY (2016)
Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer
Srikanth Santhanam et al.
TRANSLATIONAL RESEARCH (2016)
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2016)
PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang et al.
ONCOTARGETS AND THERAPY (2016)
Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis
Ya-Ling Hsu et al.
ONCOTARGET (2016)
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
Josephine F. Trott et al.
ONCOTARGET (2016)
Dietary tryptophan depletion in humans using a simplified two amino acid formula - a pilot study
Maike Linden et al.
FOOD & NUTRITION RESEARCH (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Interferon-alpha treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats
Christina Weide Fischer et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder
Jonathan Savitz et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue
Sangmi Kim et al.
CANCER (2015)
The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment
Johanna M. Gostner et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
Gislaine Z. Reus et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Cancer-Related Fatigue, Version 2.2015
Ann M. Berger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue
Diana M. Norden et al.
PHYSIOLOGY & BEHAVIOR (2015)
Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screening
Seema Malhotra Thekdi et al.
PSYCHO-ONCOLOGY (2015)
Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers
Johan Dahl et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer
K. Huefner et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder
Jonathan Savitz et al.
PSYCHONEUROENDOCRINOLOGY (2015)
The biology of cancer-related fatigue: a review of the literature
Leorey N. Saligan et al.
SUPPORTIVE CARE IN CANCER (2015)
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis
Annamaria Cattaneo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation
Dora Brites et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Affective Symptoms and White Matter Changes in Brain Tumor Patients
Andre Richter et al.
WORLD NEUROSURGERY (2015)
Imaging cerebral tryptophan metabolism in brain tumor-associated depression
Edit Bosnyak et al.
EJNMMI RESEARCH (2015)
Comprehensive Meta-Analysis of Excess Mortality in Depression in the General Community Versus Patients With Specific Illnesses
Pim Cuijpers et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Melanoma tumors alter proinflammatory cytokine production and monoamine brain function, and induce depressive-like behavior in male mice
Andrea Lebena et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Hippocampal dysfunctions in tumor-bearing mice
Miyoung Yang et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
Richard Metz et al.
INTERNATIONAL IMMUNOLOGY (2014)
Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment
Sonia Moretti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation
Catarina Carvalho et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology
Seray Adams et al.
PLOS ONE (2014)
Immune changes and neurotransmitters: Possible interactions in depression?
Barbara Sperner-Unterweger et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996-2013
David A. Mrazek et al.
PSYCHIATRIC SERVICES (2014)
Depression, cytokines, and pancreatic cancer
William Breitbart et al.
PSYCHO-ONCOLOGY (2014)
Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments
A. M. H. Krebber et al.
PSYCHO-ONCOLOGY (2014)
Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Jacqueline Quak et al.
PSYCHONEUROENDOCRINOLOGY (2014)
IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis
M. T. Isla Larrain et al.
TUMOR BIOLOGY (2014)
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Dinesh Vyas et al.
ONCOTARGETS AND THERAPY (2014)
A biological basis for depression in pancreatic cancer
Isadora C. Botwinick et al.
HPB (2014)
Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates
Sam Watts et al.
BMJ OPEN (2014)
Trial watch: IDO inhibitors in cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2014)
Neuroinflammation and Comorbidity of Pain and Depression
A. K. Walker et al.
PHARMACOLOGICAL REVIEWS (2014)
The biology of depression in cancer and the relationship between depression and cancer progression
Jorge Luis Sotelo et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2014)
C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy
Maria M. Pertl et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Psychological stress and melanoma: Are we meeting our patients' psychological needs?
Nadine Angele Kasparian
CLINICS IN DERMATOLOGY (2013)
Serotonin - Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Gregory Oxenkrug
CURRENT DRUG TARGETS (2013)
Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry
Floortje Mols et al.
JOURNAL OF CANCER SURVIVORSHIP (2013)
Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation
Martina M. Hughes et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Kynurenines: from the perspective of major psychiatric disorders
Aye M. Myint
FEBS JOURNAL (2012)
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Martin Schaefer et al.
JOURNAL OF HEPATOLOGY (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Evaluation of Current Cancer Immunotherapy Hemato-Oncology
Christopher S. Hourigan et al.
CANCER JOURNAL (2011)
Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
Jessica Godin-Ethier et al.
CLINICAL CANCER RESEARCH (2011)
Association between increased tryptophan degradation and depression in cancer patients
Katharina Kurz et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2011)
Serum Tryptophan and Kynurenine Concentrations as Parameters for Indoleamine 2,3-Dioxygenase Activity in Patients With Endometrial, Ovarian, and Vulvar Cancer
Renske A. de Jong et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
Alex J. Mitchell et al.
LANCET ONCOLOGY (2011)
Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas
Klaus Laimer et al.
ORAL ONCOLOGY (2011)
Immune system to brain signaling: Neuropsychopharmacological implications
Lucile Capuron et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Fluoxetine Affords Robust Neuroprotection in the Postischemic Brain Via Its Anti-inflammatory Effect
Chae-Moon Lim et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
J. C. O'Connor et al.
MOLECULAR PSYCHIATRY (2009)
Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation
Leah M. Pyter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A High-Resolution Structure of the Pre-microRNA Nuclear Export Machinery
Chimari Okada et al.
SCIENCE (2009)
High expression of indoleamine 2,3-dioxygenase gene in prostate cancer
Chantal Feder-Mengus et al.
EUROPEAN JOURNAL OF CANCER (2008)
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer
Andrew H. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-α:: Course and relationship with psychiatric status
Arthur R. Van Gool et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2008)
Diminished quality of life in patients with cancer correlates with tryptophan degradation
Katharina Schroecksnadel et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Interferon-α influences tryptophan metabolism without inducing psychiatric side effects
Marjolein Bannink et al.
NEUROPSYCHOBIOLOGY (2007)
Mood, anxiety, and physical illness: Body and mind, or mind and body?
Richard Balon
DEPRESSION AND ANXIETY (2006)
Interferon-alpha-induced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment
L Capuron et al.
BIOLOGICAL PSYCHIATRY (2003)
分享论文
